2nd Annual Lytham Partners Healthcare Investor Summit
Logotype for Viemed Healthcare Inc

Viemed Healthcare (VMD) 2nd Annual Lytham Partners Healthcare Investor Summit summary

Event summary combining transcript, slides, and related documents.

Logotype for Viemed Healthcare Inc

2nd Annual Lytham Partners Healthcare Investor Summit summary

8 Jul, 2026

Business overview and differentiation

  • Specializes in home-based complex respiratory therapy, serving patients with severe COPD and neuromuscular diseases, and offers additional services like sleep apnea, oxygen therapy, behavioral health, and staffing.

  • Diversified revenue streams: 50% complex respiratory, 20% sleep apnea, 10% oxygen therapy, with the remainder from staffing, behavioral health, and complementary products.

  • High-touch model integrates respiratory therapists into hospital care teams, leveraging proprietary technology for in-home care and data collection.

  • Sales process focuses on training clinicians as sales reps, creating a unique competitive advantage difficult for larger players to replicate.

  • 70% of revenue is recurring, primarily from equipment rentals, with the rest from transactional sales.

Strategic evolution and growth drivers

  • Transitioned from a 90% ventilator-focused company to a diversified provider through intentional M&A and organic growth.

  • Published clinical data demonstrating a 16% reduction in mortality and fewer hospital admissions, establishing industry leadership and influencing CMS regulations.

  • Recent CMS national coverage determination (NCD) provides a regulatory framework that offers a competitive edge and supports further growth.

  • Organic growth driven by expanding into underserved populations, scaling sleep apnea services, and leveraging private contracts.

  • Acquisitions, such as Lehan's Medical, fill geographic gaps and add new product lines like maternal health, with plans to expand these offerings.

Financial management and capital allocation

  • Maintains a disciplined approach to capital allocation, prioritizing organic growth, followed by M&A, debt repayment, and share buybacks.

  • EBITDA margins remain stable in the low 20% range despite diversification, with potential for future expansion through operating leverage and technology adoption.

  • Uses AI and technology to drive operational efficiencies in revenue cycle, billing, and audit processes.

  • Conservative debt management, with quick repayment after acquisitions and a history of positive net income and free cash flow.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more